XPENG INC - ADR (XPEV) Stock Fundamental Analysis

NYSE:XPEV • US98422D1054

17.76 USD
-0.42 (-2.31%)
At close: Feb 26, 2026
17.65 USD
-0.11 (-0.62%)
After Hours: 2/26/2026, 8:04:12 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Overall XPEV gets a fundamental rating of 4 out of 10. We evaluated XPEV against 35 industry peers in the Automobiles industry. XPEV scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. XPEV is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • XPEV had negative earnings in the past year.
  • XPEV had a positive operating cash flow in the past year.
  • In the past 5 years XPEV always reported negative net income.
  • In the past 5 years XPEV reported 4 times negative operating cash flow.
XPEV Yearly Net Income VS EBIT VS OCF VS FCFXPEV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -2B -4B -6B -8B -10B

1.2 Ratios

  • XPEV's Return On Assets of -4.63% is fine compared to the rest of the industry. XPEV outperforms 65.71% of its industry peers.
  • Looking at the Return On Equity, with a value of -14.11%, XPEV is in the better half of the industry, outperforming 65.71% of the companies in the same industry.
Industry RankSector Rank
ROA -4.63%
ROE -14.11%
ROIC N/A
ROA(3y)-10.7%
ROA(5y)-10.09%
ROE(3y)-23.94%
ROE(5y)-19.52%
ROIC(3y)N/A
ROIC(5y)N/A
XPEV Yearly ROA, ROE, ROICXPEV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

  • XPEV's Gross Margin of 16.36% is fine compared to the rest of the industry. XPEV outperforms 74.29% of its industry peers.
  • XPEV's Gross Margin has improved in the last couple of years.
  • XPEV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.06%
GM growth 5YN/A
XPEV Yearly Profit, Operating, Gross MarginsXPEV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • XPEV does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for XPEV has been increased compared to 1 year ago.
  • The number of shares outstanding for XPEV has been increased compared to 5 years ago.
  • XPEV has a worse debt/assets ratio than last year.
XPEV Yearly Shares OutstandingXPEV Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
XPEV Yearly Total Debt VS Total AssetsXPEV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

  • Based on the Altman-Z score of 1.07, we must say that XPEV is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.07, XPEV is in the better half of the industry, outperforming 68.57% of the companies in the same industry.
  • The Debt to FCF ratio of XPEV is 2.65, which is a good value as it means it would take XPEV, 2.65 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of XPEV (2.65) is better than 88.57% of its industry peers.
  • XPEV has a Debt/Equity ratio of 0.78. This is a neutral value indicating XPEV is somewhat dependend on debt financing.
  • XPEV's Debt to Equity ratio of 0.78 is in line compared to the rest of the industry. XPEV outperforms 45.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 2.65
Altman-Z 1.07
ROIC/WACCN/A
WACC8.07%
XPEV Yearly LT Debt VS Equity VS FCFXPEV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B 30B 40B

2.3 Liquidity

  • A Current Ratio of 1.14 indicates that XPEV should not have too much problems paying its short term obligations.
  • XPEV has a Current ratio of 1.14. This is comparable to the rest of the industry: XPEV outperforms 42.86% of its industry peers.
  • XPEV has a Quick Ratio of 1.00. This is a normal value and indicates that XPEV is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.00, XPEV is in line with its industry, outperforming 60.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 1
XPEV Yearly Current Assets VS Current LiabilitesXPEV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • XPEV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.77%, which is quite impressive.
  • XPEV shows a strong growth in Revenue. In the last year, the Revenue has grown by 86.64%.
  • The Revenue has been growing by 77.47% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)51.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.95%
Revenue 1Y (TTM)86.64%
Revenue growth 3Y24.87%
Revenue growth 5Y77.47%
Sales Q2Q%101.76%

3.2 Future

  • XPEV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.29% yearly.
  • The Revenue is expected to grow by 30.52% on average over the next years. This is a very strong growth
EPS Next Y74.6%
EPS Next 2Y49.95%
EPS Next 3Y38.07%
EPS Next 5Y23.29%
Revenue Next Year91%
Revenue Next 2Y62.41%
Revenue Next 3Y46.35%
Revenue Next 5Y30.52%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
XPEV Yearly Revenue VS EstimatesXPEV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 50B 100B 150B 200B
XPEV Yearly EPS VS EstimatesXPEV Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 5 -5 -10

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • XPEV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • A Price/Forward Earnings ratio of 80.32 indicates a quite expensive valuation of XPEV.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of XPEV indicates a somewhat cheap valuation: XPEV is cheaper than 68.57% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.13, XPEV is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 80.32
XPEV Price Earnings VS Forward Price EarningsXPEV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60 80

4.2 Price Multiples

  • 88.57% of the companies in the same industry are more expensive than XPEV, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.38
EV/EBITDA N/A
XPEV Per share dataXPEV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • XPEV's earnings are expected to grow with 38.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y49.95%
EPS Next 3Y38.07%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for XPEV!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

XPENG INC - ADR

NYSE:XPEV (2/26/2026, 8:04:12 PM)

After market: 17.65 -0.11 (-0.62%)

17.76

-0.42 (-2.31%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)11-17
Earnings (Next)03-18
Inst Owners12.75%
Inst Owner Change-8.71%
Ins Owners0.25%
Ins Owner ChangeN/A
Market Cap16.94B
Revenue(TTM)70.57B
Net Income(TTM)-4.28B
Analysts80.59
Price Target27.75 (56.25%)
Short Float %9.89%
Short Ratio4.9
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)41.32%
Min EPS beat(2)34.81%
Max EPS beat(2)47.83%
EPS beat(4)2
Avg EPS beat(4)18.11%
Min EPS beat(4)-8.69%
Max EPS beat(4)47.83%
EPS beat(8)4
Avg EPS beat(8)16.95%
EPS beat(12)4
Avg EPS beat(12)3.67%
EPS beat(16)6
Avg EPS beat(16)-1.04%
Revenue beat(2)1
Avg Revenue beat(2)-0.37%
Min Revenue beat(2)-3.26%
Max Revenue beat(2)2.52%
Revenue beat(4)2
Avg Revenue beat(4)-0.21%
Min Revenue beat(4)-3.26%
Max Revenue beat(4)2.52%
Revenue beat(8)2
Avg Revenue beat(8)-2.74%
Revenue beat(12)2
Avg Revenue beat(12)-5.64%
Revenue beat(16)5
Avg Revenue beat(16)-2.91%
PT rev (1m)-0.99%
PT rev (3m)1.09%
EPS NQ rev (1m)-6.89%
EPS NQ rev (3m)-6.89%
EPS NY rev (1m)2.13%
EPS NY rev (3m)-10.11%
Revenue NQ rev (1m)-0.41%
Revenue NQ rev (3m)-0.41%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.04%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 80.32
P/S 1.93
P/FCF 11.38
P/OCF 8.94
P/B 3.84
P/tB 4.48
EV/EBITDA N/A
EPS(TTM)-0.44
EYN/A
EPS(NY)0.22
Fwd EY1.24%
FCF(TTM)1.56
FCFY8.79%
OCF(TTM)1.99
OCFY11.18%
SpS9.2
BVpS4.63
TBVpS3.96
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.63%
ROE -14.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.36%
FCFM 16.96%
ROA(3y)-10.7%
ROA(5y)-10.09%
ROE(3y)-23.94%
ROE(5y)-19.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.06%
GM growth 5YN/A
F-Score6
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 2.65
Debt/EBITDA N/A
Cap/Depr 129.52%
Cap/Sales 4.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 1
Altman-Z 1.07
F-Score6
WACC8.07%
ROIC/WACCN/A
Cap/Depr(3y)238.42%
Cap/Depr(5y)371.52%
Cap/Sales(3y)10.3%
Cap/Sales(5y)14.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.95%
EPS Next Y74.6%
EPS Next 2Y49.95%
EPS Next 3Y38.07%
EPS Next 5Y23.29%
Revenue 1Y (TTM)86.64%
Revenue growth 3Y24.87%
Revenue growth 5Y77.47%
Sales Q2Q%101.76%
Revenue Next Year91%
Revenue Next 2Y62.41%
Revenue Next 3Y46.35%
Revenue Next 5Y30.52%
EBIT growth 1Y26.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year87.98%
EBIT Next 3Y41.34%
EBIT Next 5Y30.46%
FCF growth 1Y164.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y206.97%
OCF growth 3YN/A
OCF growth 5YN/A

XPENG INC - ADR / XPEV FAQ

Can you provide the ChartMill fundamental rating for XPENG INC - ADR?

ChartMill assigns a fundamental rating of 4 / 10 to XPEV.


What is the valuation status for XPEV stock?

ChartMill assigns a valuation rating of 4 / 10 to XPENG INC - ADR (XPEV). This can be considered as Fairly Valued.


How profitable is XPENG INC - ADR (XPEV) stock?

XPENG INC - ADR (XPEV) has a profitability rating of 2 / 10.